Stay updated with breaking news from Bing Yao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of
A new Cell Reports paper from Bing Yao’s lab in Emory’s Department of Human Genetics provides insights into mechanisms underlying several neurodegenerative diseases, such as ALS and Alzheimer’s.
Companies will collaborate on investigating a novel SHP2 inhibitor in combination with furmonertinib, a highly brain-penetrant, broadly active...
Plus, investments in car subscription startup Go and online safety-focused Kidas, grants for diversity in tech and city gov safety projects, and the Science Center wrapped its Phase 1 Ventures fund.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!